7/12/2016   Perth, Australia; 12 July 2016: Regenerative medicine company Orthocell Limited today announced that it has received ethics approval to conduct a study comparing surgery for severe tennis elbow to Orthocell’s minimally invasive cell therapy Ortho-ATI™ injection. The study will be conducted by two of Australia’s leading elbow surgeons with ethics approval received from […]